Literature DB >> 18705759

British HIV Association guidelines for HIV-associated malignancies 2008.

M Bower1, S Collins, C Cottrill, K Cwynarski, S Montoto, M Nelson, N Nwokolo, T Powles, J Stebbing, N Wales, A Webb.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18705759     DOI： 10.1111/j.1468-1293.2008.00608.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  29 in total

1.  Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.

Authors:  Dong Ta Zhong; Chun Mei Shi; Qiang Chen; Jing Ze Huang; Jian Gang Liang; Dong Lin
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-11       Impact factor: 4.553

Review 2.  Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.

Authors:  Sean T Duggan; Gillian M Keating
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 3.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

4.  Cancer Treatment in Patients With HIV Infection and Non-AIDS-Defining Cancers: A Survey of US Oncologists.

Authors:  Gita Suneja; Matthew Boyer; Baligh R Yehia; Meredith S Shiels; Eric A Engels; Justin E Bekelman; Judith A Long
Journal:  J Oncol Pract       Date:  2015-04-14       Impact factor: 3.840

5.  Cancer treatment disparities in HIV-infected individuals in the United States.

Authors:  Gita Suneja; Meredith S Shiels; Rory Angulo; Glenn E Copeland; Lou Gonsalves; Anne M Hakenewerth; Kathryn E Macomber; Sharon K Melville; Eric A Engels
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

6.  Biologic, clinical, and sociodemographic predictors of multi-agent systemic therapy for non-Hodgkin lymphoma in people living with HIV: a population-based investigation in the state of Georgia.

Authors:  Joseph Lipscomb; Jeffrey M Switchenko; Christopher R Flowers; Theresa W Gillespie; Pascale M Wortley; A Rana Bayakly; Lyn Almon; Robyn Fernando; Kevin C Ward
Journal:  Leuk Lymphoma       Date:  2019-12-18

7.  Lower Gastrointestinal Kaposi Sarcoma in HIV/AIDS: A Diagnostic Challenge.

Authors:  Titilope Olanipekun; Suaka Kagbo-Kue; Adekunbi Egwakhe; Maxi Mayette; Mesfin Fransua; Michael Flood
Journal:  Gastrointest Tumors       Date:  2019-07-18

8.  Non AIDS Kaposi's Sarcoma Leading to Lower Extremities Wounds, Case Presentations and Discussion.

Authors:  Laemthong Phavixay; David Raynolds; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-01-19

9.  HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

Authors:  Silvia Montoto; Kate Shaw; Jessica Okosun; Shreyans Gandhi; Paul Fields; Andrew Wilson; Milensu Shanyinde; Kate Cwynarski; Robert Marcus; Johannes de Vos; Anna Marie Young; Melinda Tenant-Flowers; Chloe Orkin; Margaret Johnson; Daniella Chilton; John G Gribben; Mark Bower
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

10.  Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.

Authors:  Francesca Cainelli; Alfredo Vallone
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.